A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas

NCT00001566 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

NIH

Sponsor class

Conditions

Ewing's Sarcoma
Rhabdomyosarcoma

Interventions

BIOLOGICAL: therapeutic autologous dendritic cells
DRUG: indinavir sulfate
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

National Cancer Institute (NCI)